ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,080.70
-0.19%
S&P 500
5,702.55
-0.19%
Dow Jones
42,063.36
0.09%
US Dollar vs Yen
143.825
0.01%
Brent Oil
74.135
0.00%
Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Puma Biotechnology Inc (PBYI)

  7. Puma Biotechnology Inc (PBYI) ニュース

PBYI

Puma Biotechnology (PBYI)

Puma Biotechnology Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:PBYI
日付受信時刻ニュースソース見出しコード企業名
2024/09/1622 : 01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/09/0405 : 15Business WirePuma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:PBYIPuma Biotechnology Inc
2024/08/2806 : 02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PBYIPuma Biotechnology Inc
2024/08/1522 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/08/0722 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/08/0706 : 23Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/08/0205 : 41Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PBYIPuma Biotechnology Inc
2024/08/0205 : 17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBYIPuma Biotechnology Inc
2024/08/0205 : 05Business WirePuma Biotechnology Reports Second Quarter Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1908 : 11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1908 : 06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1907 : 57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1905 : 10Business WirePuma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial ResultsNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1809 : 43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1809 : 39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/1809 : 36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/07/0306 : 30Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1808 : 18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1410 : 46Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1410 : 44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1410 : 43Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/1410 : 41Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PBYIPuma Biotechnology Inc
2024/06/0806 : 37Business WirePuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PBYIPuma Biotechnology Inc
2024/06/0403 : 33Business WirePuma Biotechnology Announces Presentation of Findings from a Phase I/Ib Study of Alisertib in Advanced EGFR-Mutated Lung CancerNASDAQ:PBYIPuma Biotechnology Inc
2024/06/0223 : 01Business WirePuma Biotechnology Announces Presentation of Findings from a Phase II Study of Alisertib in Endocrine-Resistant Metastatic Breast Cancer (TBCRC 041)NASDAQ:PBYIPuma Biotechnology Inc
2024/05/2822 : 00Business WirePuma Biotechnology to Join Russell 3000 IndexNASDAQ:PBYIPuma Biotechnology Inc
2024/05/2406 : 15Business WirePuma Biotechnology Announces Publication of Alisertib Abstract Titles for the 2024 ASCO Annual MeetingNASDAQ:PBYIPuma Biotechnology Inc
 Showing the most relevant articles for your search:NASDAQ:PBYI

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
NYSE
MCD
McDonalds
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
AAPL
Apple
COIN
ETHUSD
Ethereum
COIN
SOLUSD
Solana
COIN
DOGEUSD
Dogecoin
COIN
AVAXUSD
Avalanche
NASDAQ
AMZN
Amazon.com
USI
USTECH100
US Tech 100
NYSE
VZ
Verizon Communications
NYSE
KO
Coca Cola
FX
USDEUR
US Dollar vs Euro
AMEX
SPY
SPDR S&P 500
CCOM
US100
US Tech 100
AMEX
XLF
Financial Select Sector
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有